Febrile seizures

The controversy continues

D. K. Moore, K. L. Massey, Stephanie Phelps

Research output: Contribution to journalArticle

Abstract

Many aspects concerning the treatment of febrile seizures have been researched in order to identify the optimal drug regimen that will provide the safest and most effective means of prophylaxis. The need for an agent that can be administered intermittently is evidenced by the potential adverse consequences of continuous administration of anticonvulsant therapy. The intermittent use of diazepam has been the subject of several studies, all of which appear to support its use. Because simple febrile seizures are often benign, the proposed selective prophylaxis of only high recurrence risk children also deserves further consideration.

Original languageEnglish (US)
JournalHospital Pharmacy
Volume23
Issue number3
StatePublished - Jan 1 1988

Fingerprint

Febrile Seizures
Diazepam
Anticonvulsants
Pharmaceutical Preparations
Recurrence
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Febrile seizures : The controversy continues. / Moore, D. K.; Massey, K. L.; Phelps, Stephanie.

In: Hospital Pharmacy, Vol. 23, No. 3, 01.01.1988.

Research output: Contribution to journalArticle

Moore, DK, Massey, KL & Phelps, S 1988, 'Febrile seizures: The controversy continues', Hospital Pharmacy, vol. 23, no. 3.
Moore, D. K. ; Massey, K. L. ; Phelps, Stephanie. / Febrile seizures : The controversy continues. In: Hospital Pharmacy. 1988 ; Vol. 23, No. 3.
@article{2a8381970718420ba1f880d23ea3ba37,
title = "Febrile seizures: The controversy continues",
abstract = "Many aspects concerning the treatment of febrile seizures have been researched in order to identify the optimal drug regimen that will provide the safest and most effective means of prophylaxis. The need for an agent that can be administered intermittently is evidenced by the potential adverse consequences of continuous administration of anticonvulsant therapy. The intermittent use of diazepam has been the subject of several studies, all of which appear to support its use. Because simple febrile seizures are often benign, the proposed selective prophylaxis of only high recurrence risk children also deserves further consideration.",
author = "Moore, {D. K.} and Massey, {K. L.} and Stephanie Phelps",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "23",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "3",

}

TY - JOUR

T1 - Febrile seizures

T2 - The controversy continues

AU - Moore, D. K.

AU - Massey, K. L.

AU - Phelps, Stephanie

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Many aspects concerning the treatment of febrile seizures have been researched in order to identify the optimal drug regimen that will provide the safest and most effective means of prophylaxis. The need for an agent that can be administered intermittently is evidenced by the potential adverse consequences of continuous administration of anticonvulsant therapy. The intermittent use of diazepam has been the subject of several studies, all of which appear to support its use. Because simple febrile seizures are often benign, the proposed selective prophylaxis of only high recurrence risk children also deserves further consideration.

AB - Many aspects concerning the treatment of febrile seizures have been researched in order to identify the optimal drug regimen that will provide the safest and most effective means of prophylaxis. The need for an agent that can be administered intermittently is evidenced by the potential adverse consequences of continuous administration of anticonvulsant therapy. The intermittent use of diazepam has been the subject of several studies, all of which appear to support its use. Because simple febrile seizures are often benign, the proposed selective prophylaxis of only high recurrence risk children also deserves further consideration.

UR - http://www.scopus.com/inward/record.url?scp=0023924255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023924255&partnerID=8YFLogxK

M3 - Article

VL - 23

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 3

ER -